Veerhealth Care Ltd has announced that its Board of Directors will meet on March 28, 2026, to consider raising funds through equity shares, convertible securities, or other instruments. The company also confirmed closure of its trading window in line with SEBI’s insider trading regulations.
Veerhealth Care Ltd has formally notified the Bombay Stock Exchange that its upcoming board meeting will deliberate on multiple fundraising avenues. The move signals the company’s intent to strengthen its capital base and pursue growth opportunities.
Board Meeting Details
The meeting is scheduled for March 28, 2026, at 3:00 PM at the company’s registered office in Mumbai. The agenda includes evaluating fundraising options such as preferential issue, rights issue, qualified institutional placement (QIP), or other suitable modes, subject to regulatory approvals.
Trading Window Closure
In compliance with SEBI’s Prohibition of Insider Trading Regulations, the company has announced closure of its trading window from March 20, 2026, until 48 hours after the conclusion of the board meeting. This ensures transparency and prevents insider trading during sensitive corporate actions.
Shareholder Approval
The Board will also consider convening an Extraordinary General Meeting or initiating a postal ballot process to seek shareholder approval for the proposed fundraising plan.
Key Highlights
-
Board meeting on March 28, 2026
-
Fundraising options: equity, convertible securities, preferential issue, rights issue, QIP
-
Trading window closed until 48 hours post-meeting
-
Shareholder approval to be sought via EGM or postal ballot
Sources: Company filing with BSE dated March 20, 2026